Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BNTX - How Will Sorrento Therapeutics Deal With the Added COVID-19 Competition?


BNTX - How Will Sorrento Therapeutics Deal With the Added COVID-19 Competition?

In this video from Motley Fool Live recorded on Nov. 12, executives from Sorrento Therapeutics (NASDAQ: SRNE) talk about how the company's COVID-19 therapeutic antibodies -- STI-1499 and STI-2020 -- can coexist with the coronavirus vaccines.

Since the recording, both Moderna (NASDAQ: MRNA) and the duo of Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) have reported data showing their vaccines can reduce the likelihood of severe cases of COVID-19 compared to placebo.

Continue reading

For further details see:

How Will Sorrento Therapeutics Deal With the Added COVID-19 Competition?
Stock Information

Company Name: BioNTech SE
Stock Symbol: BNTX
Market: NYSE
Website: biontech.de

Menu

BNTX BNTX Quote BNTX Short BNTX News BNTX Articles BNTX Message Board
Get BNTX Alerts

News, Short Squeeze, Breakout and More Instantly...